New data chief joins Alphatec Holdings
Alphatec Holdings (ATEC) just added Thomas “Tommy” Carls as Executive Vice President of Data Intelligence and Strategy, a fresh leadership role aimed at coordinating the company’s spine surgery data and analytics efforts.
Recent trading has been volatile for Alphatec Holdings, with the share price gaining 13.44% over the past 30 days and 16.40% across 90 days. However, the year-to-date share price return is down 48.36%, and the 1-year total shareholder return has declined 20.30%, which points to short-term momentum rebuilding after a tougher stretch for longer term investors.
Compare Alphatec Holdings' data driven spine focus with 33 healthcare AI stocks that are also leaning on analytics and AI to reshape how procedures are planned and executed.
Alphatec Holdings has bounced hard in the short term yet still carries steep drawdowns over one and three years. Does that reset leave more upside than downside for buyers once the current valuation is lined up against the fundamentals?
Most Popular Narrative: 33% Undervalued
Compared with Alphatec Holdings' last close at $10.72, the most followed valuation narrative pegs fair value at $16.00, which frames the current share price as a sizeable discount that depends heavily on execution of its spine ecosystem plan.
Ongoing innovation in integrated procedural solutions and the forthcoming launch of Valence (robotics/navigation) positions the company to capitalize on the accelerating adoption of advanced healthcare technologies, likely boosting both future revenue and long-term margin expansion.
Investments in foundational informatics, data-driven solutions (EOS, SafeOp), and a fully integrated surgical ecosystem are expected to enhance clinical outcomes and procedural efficiency, increasing pricing power and supporting sustainable earnings growth as value-based healthcare becomes more prevalent.
See why 11 investors see Alphatec Holdings as 33% undervalued.
Result: Fair Value of $16.00 (UNDERVALUED)
Still, Alphatec Holdings faces pressure from larger device rivals and ongoing operating losses, which could challenge the bullish revenue and margin narrative if the company’s growth slows.
Find out about the key risks to this Alphatec Holdings narrative.
Next Steps
Curious whether the optimism around Alphatec Holdings feels justified or stretched? Act quickly, review the data, and weigh those upside drivers against the risks by checking 3 key rewards.
Looking for more Alphatec Holdings style investment ideas?
Do not stop with Alphatec Holdings alone. Broaden your watchlist with focused screeners that surface different types of opportunities before they move beyond your preferred price or risk range.
- Target potential bargains early by scanning a curated pool of companies trading below estimated value using the 27 high quality undervalued stocks.
- Prioritize resilience by reviewing a list of solid balance sheet and fundamentals (25 results) that can help limit financial shocks when conditions turn rough.
- Hunt for lesser known opportunities through a 19 high quality undiscovered gems that filters for quality businesses the market may not be watching yet.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com